Reference standard for cholesterol evaluation in serum obtained by isotope dilution mass spectrometry

  • B. Malavasi
  • D. Colombo
  • G. Galli

Abstract

For the analysis by isotopic dilution, a sample containing the analyte to he measured is mixed with a known amount of the same analyte isotopically labelled, By gaschromatography-mass spectrometry (GC-MS), that allows to discriminate the labelled and the unlabelled compound on the basis of their molecular weight, it is possible to determine the intensity ratio of the two isotopes. The use as internal reference of the labelled analyte, that exhibits chemical-physical properties identical to the natural isotope, allows to not take into account the recoveries obtained from the different analytical steps, and the variability of the instrumental response, because the ratio between the two isotopic species remains unchanged during the overall analytical procedure. The analyte concentration is calculated on the basis of the volume of the specimen, the known amount of labelled analyte added, and the intensity ratio of specific ions of the two isotopes determined by GC-MS.

Keywords

Cholesterol Concentration Isotope Dilution Mass Spectrometry Isotopic Species Label Cholesterol Unlabelled Compound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    A. Cohen,H.S. Hertz, J, Mandel, R.C. Paule, R, Schaffer, L.T. Sniegoski, T. Sun, M.J. Welch, E. White V (1980) Clin, Chem. 26 /7: 660Google Scholar
  2. (2).
    L.P. Cawley, B.O. Musser, S. Cambell, W. Faucette (1963) Am, J. Clin. Pathol, 39: 450Google Scholar
  3. (3).
    J.L. Driscoll, D. Aubuchon, M. Descoteaux, H.F. Martin (1971) Anal. Chem, 43: 1196PubMedCrossRefGoogle Scholar
  4. (4).
    J.P. Blomhoff, (1973) Clin, Chim. Acta 43: 257CrossRefGoogle Scholar
  5. (5).
    P. Roschlau,E. Berut, W. Gruber (1974) Z. Klin. Biochem. 12: 403Google Scholar
  6. (6).
    C.C. Sweeley, W.H. Holmsted, R. Ryhage, (1966) Anal, Chem. 38: 1549PubMedCrossRefGoogle Scholar
  7. (7).
    C.G. Hammar, W.H. Holmsted, R. Ryhage, (1968) Anal. Chem. 25: 532Google Scholar
  8. (8).
    J.P. Cali, Abstracts of the Xth International Congress of Clinical Chemistry, Mexico D.F., Avelar Hnos. Impresores, Mexico D.F., 1978, p,30Google Scholar
  9. (9).
    I, Bjoerkhem, R. Blomstrand, L. Svensson, (1974) Clin. Chim, Acta 54: 185.CrossRefGoogle Scholar
  10. (10).
    L.F. Fieser (1953) JACS, 75: 5421CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • B. Malavasi
    • 1
  • D. Colombo
    • 2
  • G. Galli
    • 1
  1. 1.School of PharmacyInstitute of Pharmacological SciencesItaly
  2. 2.Department of Chemistry and Biochemistry, School of MedicineUniversity of MilanItaly

Personalised recommendations